Review criteria |
Definitive ChemoRT or RT |
Post-Operative ChemoRT or RT |
Points |
H&P |
Relevant history stated |
Duration of symptoms. Alcohol and tobacco history and current usage detailed. |
Duration of symptoms. Alcohol and tobacco history and current usage detailed. |
|
|
Relevant physical findings |
Full H&N exam including indirect mirror exam or fiberoptic exam. Review of prior video stroboscopy allowed. |
Full H&N exam including statement regarding current state of post-operative healing. |
|
|
Appropriate staging |
TNM stage should be based on all available data including from physical exam and CT scan. PET information if available. MRI if clinically indicated. |
T and N stage confirmed by pathology report. |
|
|
Pathology report/Surgical reports |
Diagnosis of malignancy confirmed by biopsy. |
Histology, size of primary tumor, margin status, size, number and location of involved nodes, presence of extracapsular extension, LVSI, perineural invasion. |
|
|
Appropriate patient selection for treatment/Discussion of options |
If appropriate was surgery first or induction chemotherapy discussed as possible treatment options? |
If chemotherapy given, are the indications given: positive surgical margins, extracapsular extension, other? |
|
|
Simulation |
Appropriate consent form listing side effects |
- mucositis
- xerostomia
- Altered taste/smell
- Hoarseness
- Skin erythema
- Ear pain and/or pressure
- Fatigue
- Weight loss
- Loss of teeth, cavities, hypersensitivity of teeth
- thyroid dysfunction
- Damage to spinal cord, nerves in neck, jawbone, voicebox, skin, or other parts of head and neck that could require surgical correction
- Brachial Plexopathy
- Breathing problems
- Difficulty with swallowing or eating that may require a long term or permanent feeding tube
- Possibility of inhaling food and/or liquids into the lungs which could result in pneumonia
- Serious ear infections and/or hearing loss
- Damage to the spinal cord leading to permanent weakness and/or symptoms like a stroke
|
- mucositis
- xerostomia
- Altered taste/smell
- Hoarseness
- Skin erythema
- Ear pain and/or pressure
- Fatigue
- Weight loss
- Loss of teeth, cavities, hypersensitivity of teeth
- thyroid dysfunction
- Damage to spinal cord, nerves in neck, jawbone, voicebox, skin, or other parts of head and neck that could require surgical correction
- Brachial Plexopathy
- Breathing problems
- Difficulty with swallowing or eating that may require a long term or permanent feeding tube
- Possibility of inhaling food and/or liquids into the lungs which could result in pneumonia
- Serious ear infections and/or hearing loss
- Damage to the spinal cord leading to permanent weakness and/or symptoms like a stroke
|
|
|
Appropriate treatment plan note |
Definition of what is to be included in the PTV high dose and elective dose. Plans on using chemotherapy. Rationale for using IMRT if done. |
Definition of what is to be included in the PTV high dose and elective dose. Plans on using chemotherapy. Rationale for using IMRT if done. |
|
|
Appropriate simulation note/process |
CT-based, slice thickness of ≤ 3mm, images from top of head to carina. Set up documentation. |
CT-based, slice thickness of ≤ 3mm, images from top of head to carina. Set up documentation. |
|
|